Our mission
Use proven scientific methods and rigorous research to develop and deliver nutraceuticals that support healthier, happier lives for everyone, everywhere.
About Sphaera
Sphaera Pharma is an R&D focused biotech committed to bringing innovative products and therapies to patients. Our alliance with Blue Oak Nutraceuticals, Inc. is another step in making global, technology-driven, quality products available to users in India and other markets that we serve. The foundation of Mitokatlyst was based on a lot of early research done at Sphaera’s labs. We believe that interventions in current paradigm must be viewed differently, with a holistic perspective, backed by strong scientific evidence. Sphaera is guided by this philosophy in everything that we do and are committed to Bringing Innovation to Patients
Learn more about Sphaera
About Blue Oak Nutraceuticals
Blue Oak Nutraceuticals is a company focused on developing and delivering nutraceuticals, using scientific research to create products that support healthier lives. They are known for their product Mitokatlyst™-E, which is designed to support mitochondrial health and potentially improve energy levels and overall well-being. The company emphasizes rigorous science and aims to translate cutting-edge research into practical solutions. The company is founded by Sundeep Dugar, PhD, Monica Pal and Sonya Pelia.
Sundeep is also the founder of Sphaera and is the Chief Scientific Advisor of Sphaera Pharma.
Our scientist
Dr. Sundeep Dugar
Post-doctoral fellowship Swiss Federal Institute of Technology (ETH)
Post-doctoral fellowship Cornell University
Ph.D. Chemistry University of California Davis
+ Read more
He has almost 35+ years of experience and great success in small-molecule drug discovery and development in oncology, – inflammation,
the central nervous system, and cardiovascular and metabolic disorders.
Founder of Advantium Pharma (2005), sold to Sequoia Capital; Sphaera Pharma (2008) establishing a new and unique model for drug discovery and development; Epirium Bio (2019), a clinical-stage biopharmaceutical company; Aayam Therapeutics (2022) advancing therapeutics for patients.
15 years ago, research in mitochondrial bioenergetics piqued his interest, and he has devoted significant time and resources to this research ever since.
- Co-inventor of Zetia® (ezetimibe) and Vytorin® (ezetimibe/simvastatin) at Bristol-Myers Squibb and Schering-Plough. American Chemical Society’s 2005 National Inventor of the Year Award and 2004 Heroes of Chemistry Award.
- Co-author of 70+ publications and presentations, and co-inventor on 100+ issued and applied patents.
- Co-organizer of the R. Bryan Miller Symposium at UC Davis for 20+ years, where he is Senior Research Fellow, helped create the UC Davis Pharmaceutical Chemistry program, and previously served as Trustee of the UC Davis Foundation.
Promote muscle strength and endurance in less than 3 months*
